Skip to main content
logo
BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
1.450
-0.020 (-1.36%)
At close: Sep 4, 2026, 4:00 PM EDT
1.420
-0.030 (-2.07%)
After-hours: Sep 4, 2026, 7:30 PM EDT

BioNexus Gene Lab Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4959165365
Market Cap Growth
-58.17%85.79%-46.33%-94.33%-54.75%54.35%
Enterprise Value
1713164363
Last Close Price
1.453.952.805.30114.00255.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----485.24
PS Ratio
1.361.260.530.9615.1027.29
PB Ratio
0.451.080.600.9724.7650.80
P/TBV Ratio
0.551.080.600.9724.7650.80
P/FCF Ratio
----331.6260792.56
P/OCF Ratio
----299.0739809.47

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.340.900.120.3414.9727.17
EV/EBITDA Ratio
-----316.52
EV/EBIT Ratio
-----343.88
EV/FCF Ratio
----328.7460523.49

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.030.030.020.010.01
Debt / EBITDA Ratio
-----0.07
Debt / FCF Ratio
----0.1112.83
Net Debt / Equity Ratio
-0.41-0.44-0.50-0.60-0.31-0.28
Net Debt / EBITDA Ratio
1.211.282.311.9615.97-1.78
Net Debt / FCF Ratio
3.752.031.792.93-4.14-341.22
Asset Turnover
0.350.750.870.971.191.36
Inventory Turnover
2.936.146.517.987.748.23
Quick Ratio
4.569.003.104.242.522.39
Current Ratio
6.0810.463.814.933.013.07
Return on Equity (ROE)
-33.66%-35.24%-17.78%-32.21%-5.14%10.86%
Return on Assets (ROA)
-18.99%-19.68%-10.86%-18.85%-1.50%6.70%
Return on Invested Capital (ROIC)
-60.88%-69.07%-47.15%-71.66%-4.53%16.67%
Return on Capital Employed (ROCE)
-34.80%-35.50%-22.40%-31.10%-3.30%14.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-60.54%-31.96%-31.80%-28.08%-0.22%0.21%
FCF Yield
-20.07%-20.09%-46.17%-21.05%0.30%0.00%
Buyback Yield / Dilution
-20.61%-4.20%-12.24%-10.17%-0.99%-66.36%
SEC Filings: 10-K · 10-Q